Skip to main content

Table 4 Median (range) bronchoalveolar lavage fluid (BALF) and serum levels (pg/ml) of the measured cytokines and adhesion molecules in acute respiratory distress syndrome patients (group A) whether or not they survived

From: The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome

 

BALF

Serum

 

Survivors (n = 11)

Non-survivors (n = 12)

Survivors (n = 11)

Non-survivors (n = 12)

IL-1

215 (10–435)

450 (0–2030)

130 (50–558)

400 (3–908)

TNF-α

600 (0–2600)

310 (0–1428)

362 (116–790)

212 (60–695)

sICAM-1

960 (540–2460)

980 (680–2140)

160 (66–300)

360* (66–1120)

sVCAM

312 (156–392)

356 (236–528)

100 (66–250)

380** (140–900)

  1. * P < 0.05, ** P < 0.01, versus survivors group. Comparisons were done using the Mann-Whitney test. IL-1 = interleukin-1; TNF-α = tumour necrosis factor-alpha; sICAM-1 = serumintercellular adhesion molecule-1; sVCAM = serum vascular adhesion molecule